O-015 Association Between Depth of Response (dpr) and Survival Outcomes in RAS-wild-type (wt) Patients with Metastatic Colorectal Cancer (mcrc) Receiving First-Line FOLFOX or FOLFIRI Plus Cetuximab Once-Every-2-weeks in the APEC Study
Annals of Oncology（2016）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined